Table 3 -.

Univariable and multivariable analyses of predictors of cancer specific survival and recurrence free survival for patients who underwent nephrectomy for locoregional sarcomatoid RCC (n=112)

	CSS Univariable			CSS Multivariable			RFS Univariable			RFS Multivariable
Variable	HR	95% CI	p	HR	95% CI	p	HR	95% CI	p	HR	95% CI	p
Age	1.01	0.98, 1.04	0.4				1.00	0.98, 1.02	0.9
Sex
Female	Ref.			Ref.			Ref.
Male	0.46	0.25, 0.86	0.015	0.51	0.27, 0.97	0.040	0.73	0.44, 1.21	0.2
BMI (n=111)	0.98	0.92, 1.05	0.6				1.00	0.96, 1.04	>0.9
Smoking Status (n=111)
Current	Ref.						Ref.
Former	0.47	0.17, 1.25	0.13				1.24	0.48, 3.19	0.7
Never	0.44	0.16, 1.18	0.10				1.33	0.52, 3.40	0.6
Histology
ccRCC	Ref.						Ref.
non-ccRCC	1.27	0.67, 2.42	0.5				0.66	0.37, 1.16	0.2
Tumor Size	1.02	0.95, 1.09	0.7				1.08	1.03, 1.14	0.003	1.07	1.01, 1.13	0.017
T Stage Group (n=111)
T1/T2	Ref.			Ref.			Ref.			Ref.
T3/T4	2.65	1.27, 5.53	0.010	2.41	1.15, 5.07	0.020	2.20	1.28, 3.76	0.004	2.00	1.17, 3.43	0.012
N Stage
N0/Nx	Ref.						Ref.
N1/N2	2.13	1.06, 4.30	0.035				1.95	1.05, 3.62	0.036
WBC	1.09	1.03, 1.16	0.005				1.03	0.98, 1.09	0.3
RBC	0.69	0.38, 1.27	0.2				0.93	0.59, 1.46	0.8
PLT/100 (n=109)	1.06	0.85, 1.31	0.6				1.10	0.93, 1.30	0.3
Neutrophils	1.11	1.04, 1.18	0.002				1.04	0.98, 1.10	0.2
Lymphocytes	1.02	0.58, 1.81	>0.9				0.96	0.62, 1.47	0.8
Monocytes	2.25	0.84, 6.07	0.11				1.63	0.80, 3.32	0.2
NLR	1.16	1.05, 1.28	0.003	1.10	1.00, 1.22	0.049	1.09	1.00, 1.20	0.059
LMR	0.84	0.68, 1.04	0.11				0.86	0.73, 1.00	0.050	0.91	0.78, 1.06	0.2
PLR/100 (n=109)	1.09	0.84, 1.42	0.5				1.16	0.93, 1.43	0.2

CSS = cancer specific survival; RFS = recurrence free survival; BMI = body mass index; ccRCC = clear cell renal cell carcinoma; WBC = white blood cells; RBC = red blood cells; PLT = platelets; NLR = neutrophil-lymphocyte ratio; LMR = lymphocyte-monocyte ratio; PLR = platelet-lymphocyte ratio; Ref. = reference.